Kolkata: Prices of 42 medicines, including those used for day-to-day consumption, are likely to change following an order by ...

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...

Diabetes remission was achieved in 44 and 28% of patients in the dapagliflozin and placebo groups, respectively. HealthDay News — For patients with overweight or obesity and type 2 diabetes ...

The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or dapagliflozin had comparable long-term kidney outcomes. These findings ...

Calorie restriction, physical activity and the drug dapagliflozin caused 44% of participants in a small trial to enter diabetes remission Dapagliflozin is a sodium glucose co-transporter 2 (SGLT2) ...

Combining dapagliflozin with calorie restriction ... and 45% were treated with metformin at baseline. The calorie-restricted diet had an energy deficit of 500~750 kcal per day, with fat < 35% ...

Image Credit: Pixel-Shot/Shutterstock.com A recent BMJ study conducted a randomized trial to evaluate whether a combined therapy of dapagliflozin ... and those taking metformin exhibited HbA1c ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate ... any anti-diabetic medication other ...

The addition of dapagliflozin alongside moderate calorie restricted diet ... greater than 25 and were not taking any anti-diabetic medication other than metformin. They were also not taking weight ...

After excluding patients with a range of pre-existing conditions, a history of gastric surgery, and those taking weight loss drugs, participants were randomly assigned to either moderate calorie ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much ...